BofA upgraded Option Care Health (OPCH) to Buy from Neutral.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
- Option Care Health Announces Strong Growth and Share Repurchase
- Option Care Health reports preliminary Q4 adjusted EPS 42c-45c, consensus 35c
- Option Care Health sees FY25 adjusted EPS $1.59-$1.69, consensus $1.29
- Option Care Health price target lowered to $30 from $31 at JMP Securities